Bicycle Therapeutics plc (BCYC) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Bicycle Therapeutics plc (BCYC) Bundle
Evaluate the financial outlook of Bicycle Therapeutics plc (BCYC) like an expert! This (BCYC) DCF Calculator provides you with pre-filled financial data and full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to match your projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.8 | 10.4 | 11.7 | 14.5 | 27.0 | 33.6 | 41.8 | 52.1 | 64.8 | 80.7 |
| Revenue Growth, % | 0 | -24.72 | 12.58 | 23.65 | 86.52 | 24.51 | 24.51 | 24.51 | 24.51 | 24.51 |
| EBITDA | -30.0 | -50.4 | -64.1 | -113.0 | -183.4 | -33.6 | -41.8 | -52.1 | -64.8 | -80.7 |
| EBITDA, % | -217.56 | -484.98 | -547.84 | -781.06 | -679.86 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.0 | 1.3 | 1.4 | 3.7 | 6.5 | 5.5 | 6.8 | 8.5 | 10.5 | 13.1 |
| Depreciation, % | 6.98 | 12.39 | 12.04 | 25.49 | 24.27 | 16.23 | 16.23 | 16.23 | 16.23 | 16.23 |
| EBIT | -31.0 | -51.7 | -65.5 | -116.7 | -189.9 | -33.6 | -41.8 | -52.1 | -64.8 | -80.7 |
| EBIT, % | -224.55 | -497.36 | -559.89 | -806.55 | -704.13 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 92.1 | 136.0 | 438.7 | 339.2 | 526.4 | 33.6 | 41.8 | 52.1 | 64.8 | 80.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 7.1 | 14.6 | 11.9 | 21.2 | 24.0 | 29.6 | 36.9 | 45.9 | 57.2 | 71.2 |
| Account Receivables, % | 51.77 | 140.84 | 101.82 | 146.63 | 89.11 | 88.18 | 88.18 | 88.18 | 88.18 | 88.18 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.000007245852 | 0 | 0 | 0.000006914195 | 0 | 0.000002832009 | 0.000002832009 | 0.000002832009 | 0.000002832009 | 0.000002832009 |
| Accounts Payable | 1.9 | 1.4 | 2.7 | 6.5 | 13.1 | 9.6 | 12.0 | 15.0 | 18.6 | 23.2 |
| Accounts Payable, % | 14.12 | 13.14 | 23.26 | 44.75 | 48.38 | 28.73 | 28.73 | 28.73 | 28.73 | 28.73 |
| Capital Expenditure | -1.6 | -1.2 | -2.0 | -19.0 | -2.9 | -10.1 | -12.6 | -15.7 | -19.6 | -24.4 |
| Capital Expenditure, % | -11.27 | -11.55 | -17.35 | -131.28 | -10.86 | -30.21 | -30.21 | -30.21 | -30.21 | -30.21 |
| Tax Rate, % | -0.81303 | -0.81303 | -0.81303 | -0.81303 | -0.81303 | -0.81303 | -0.81303 | -0.81303 | -0.81303 | -0.81303 |
| EBITAT | -30.7 | -51.0 | -63.9 | -115.1 | -191.5 | -33.2 | -41.3 | -51.4 | -64.1 | -79.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -36.5 | -58.9 | -60.4 | -135.9 | -184.1 | -46.9 | -52.1 | -64.8 | -80.7 | -100.5 |
| WACC, % | 8.54 | 8.54 | 8.53 | 8.54 | 8.55 | 8.54 | 8.54 | 8.54 | 8.54 | 8.54 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -262.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -102 | |||||||||
| Terminal Value | -1,567 | |||||||||
| Present Terminal Value | -1,040 | |||||||||
| Enterprise Value | -1,303 | |||||||||
| Net Debt | -481 | |||||||||
| Equity Value | -821 | |||||||||
| Diluted Shares Outstanding, MM | 36 | |||||||||
| Equity Value Per Share | -23.08 |
What You Will Receive
- Adjustable Forecast Parameters: Effortlessly modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Comprehensive Data: Bicycle Therapeutics plc's (BCYC) financial data pre-loaded to facilitate your analysis.
- Automated DCF Calculations: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Flexible and Professional Design: A refined Excel model that can be tailored to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Customizable Clinical Parameters: Adjust essential inputs such as trial success rates, market penetration, and R&D expenditures.
- Instant Valuation Model: Generates intrinsic value, NPV, and other key metrics automatically.
- High-Precision Analytics: Leverages Bicycle Therapeutics' (BCYC) actual financial data for accurate valuation results.
- Streamlined Scenario Analysis: Easily evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download: Obtain the comprehensive Excel file featuring Bicycle Therapeutics plc's (BCYC) financial data.
- Customize: Modify projections, including revenue growth, EBITDA %, and WACC as needed.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various forecasts and analyze results immediately.
- Make Decisions: Leverage the valuation outcomes to inform your investment choices.
Why Choose This Calculator?
- Designed for Experts: A sophisticated tool utilized by researchers, financial analysts, and investment professionals.
- Comprehensive Data: Bicycle Therapeutics plc’s (BCYC) historical and projected financials integrated for precision.
- Flexible Scenario Analysis: Easily test various forecasts and assumptions with our intuitive interface.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the calculation process.
Who Should Use Bicycle Therapeutics plc (BCYC)?
- Investors: Make informed investment choices with insights into innovative therapies.
- Biotech Analysts: Streamline your research with comprehensive data on pipeline developments.
- Healthcare Consultants: Easily tailor reports and presentations for client needs in the biotech sector.
- Pharmaceutical Enthusiasts: Enhance your knowledge of cutting-edge drug development processes.
- Academics and Students: Utilize it as a valuable resource for studies in biotechnology and pharmaceutical sciences.
What the Template Contains
- Pre-Filled DCF Model: Bicycle Therapeutics plc’s (BCYC) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Bicycle Therapeutics plc’s (BCYC) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.